Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis

Abstract

In order to assess the effectiveness of monthly intravenous corticosteroids in reducing childbirth-associated acute exacerbations in multiple sclerosis (MS), we compared pregnant patients followed up in our MS clinic. During the first period (1996-1998), 22 patients did not receive any treatment after delivery. During the second period (1999-2001), following the publication of the PRIMS study, 20 patients were treated monthly with 1 g of intravenous corticosteroids during the six months of the postpartum period. In both groups the relapse rate increased during the first trimester postpartum but it was higher in the untreated group (2±0.66 [mean±SD]) compared with the treated group (0.8±0.41) (P=0.018), suggesting a beneficial effect of monthly intravenous corticosteroids.

Keywords

corticosteroid multiple sclerosis postpartum pregnancy relapses

Get full access to this article

View all access options for this article.

References

Confavreux C , Hutchinson M , Hours MM , Cortinovis-Tournaire P , Moreau T and the Pregnancy in Multiple Sclerosis Group . Rate of pregnancy-related relapse in multiple sclerosis . N Engl J Med 1998; 339: 285-291 .

Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 1983; 33: 1444-1452 .

Achiron A , Rostein Z , Noy S , Mashiach S , Dulitzky M , Achiron R. Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: a pilot study . J Neurol 1996; 243: 25-28 .

Haas J. High dose IVIG in the post partum period for prevention of exacerbation in MS . Mult Scler 2000; 6: S18-S20 .